Dr. Townsend was also removed from her duties as CEO of the Interim LSU Public Hospital in New Orleans and the Earl K. Long Medical Center in Baton Rouge, La.
The reason for Dr. Townsend’s removal was not disclosed.
In addition to being interim CEO, Dr. Kaiser will continue in his role as CMO of the LSU HCSD, where he directs system-wide population management. He has been with LSU HCSD since October 2001.
Juzar Ali, MD, the medical director of the Interim LSU Public Hospital, will now also serve as interim CEO of the hospital. Kim Sangari was appointed interim CEO of Earl K. Long Medical Center.
LSU HCSD runs seven of the 10 public hospitals overseen by the university system.
The removal comes less than two weeks after Fred Cerise was removed from his leadership position of LSU Health.
More Articles on Louisiana Hospital Executive Moves:
DeSoto Regional Health System Ends CEO Doug Efferson’s Contract
Kathy J. Bobbs Named Chair of Louisiana Hospital Association
Opelousas General Health System in Louisiana Appoints Mark Marley CEO
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
